These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 35280215)

  • 1. Human health impact of non-potable reuse of distributed wastewater and greywater treated by membrane bioreactors.
    Schoen ME; Jahne MA; Garland J
    Microb Risk Anal; 2018 Aug; 9():72-81. PubMed ID: 35280215
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk-based enteric pathogen reduction targets for non-potable and direct potable use of roof runoff, stormwater, and greywater.
    Schoen ME; Ashbolt NJ; Jahne MA; Garland J
    Microb Risk Anal; 2017; 5():32-43. PubMed ID: 31534999
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A risk-based evaluation of onsite, non-potable reuse systems developed in compliance with conventional water quality measures.
    Schoen ME; Jahne MA; Garland J
    J Water Health; 2020 Jun; 18(3):331-344. PubMed ID: 32589619
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human Health Impact of Cross-Connections in Non-Potable Reuse Systems.
    Schoen ME; Jahne MA; Garland JL
    Water (Basel); 2018 Oct; 10(10):. PubMed ID: 31297273
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drivers of Microbial Risk for Direct Potable Reuse and de Facto Reuse Treatment Schemes: The Impacts of Source Water Quality and Blending.
    Chaudhry RM; Hamilton KA; Haas CN; Nelson KL
    Int J Environ Res Public Health; 2017 Jun; 14(6):. PubMed ID: 28608808
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Life cycle assessment of decentralized greywater treatment systems with reuse at different scales in cold regions.
    Kobayashi Y; Ashbolt NJ; Davies EGR; Liu Y
    Environ Int; 2020 Jan; 134():105215. PubMed ID: 31715488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enteric pathogen reduction targets for onsite non-potable water systems: A critical evaluation.
    Jahne MA; Schoen ME; Kaufmann A; Pecson BM; Olivieri A; Sharvelle S; Anderson A; Ashbolt NJ; Garland JL
    Water Res; 2023 Apr; 233():119742. PubMed ID: 36848851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathogen reduction requirements for direct potable reuse in Antarctica: evaluating human health risks in small communities.
    Barker SF; Packer M; Scales PJ; Gray S; Snape I; Hamilton AJ
    Sci Total Environ; 2013 Sep; 461-462():723-33. PubMed ID: 23770553
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Simulation of enteric pathogen concentrations in locally-collected greywater and wastewater for microbial risk assessments.
    Jahne MA; Schoen ME; Garland JL; Ashbolt NJ
    Microb Risk Anal; 2017 Apr; 5():44-52. PubMed ID: 30148198
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of MBR and MBBR followed by UV or electrochemical disinfection for decentralized greywater treatment.
    Ongena S; de Walle AV; Mosquera-Romero S; Driesen N; Gutierrez L; Rabaey K
    Water Res; 2023 May; 235():119818. PubMed ID: 36905734
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Onsite Non-potable Reuse for Large Buildings: Environmental and Economic Suitability as a Function of Building Characteristics and Location.
    Arden S; Morelli B; Cashman S; Ma XC; Jahne M; Garland J
    Water Res; 2021 Mar; 191():116635. PubMed ID: 33434710
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantifying pathogen risks associated with potable reuse: A risk assessment case study for Cryptosporidium.
    Amoueyan E; Ahmad S; Eisenberg JNS; Pecson B; Gerrity D
    Water Res; 2017 Aug; 119():252-266. PubMed ID: 28475966
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative microbial risk assessment of a non-membrane based indirect potable water reuse system using Bayesian networks.
    Zhiteneva V; Carvajal G; Shehata O; Hübner U; Drewes JE
    Sci Total Environ; 2021 Aug; 780():146462. PubMed ID: 33774303
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative microbial risk assessment of Greywater on-site reuse.
    Shi KW; Wang CW; Jiang SC
    Sci Total Environ; 2018 Sep; 635():1507-1519. PubMed ID: 29710672
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathogen infection risk to recreational water users, associated with surface waters impacted by de facto and indirect potable reuse activities.
    Purnell S; Halliday A; Newman F; Sinclair C; Ebdon J
    Sci Total Environ; 2020 Jun; 722():137799. PubMed ID: 32197157
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of Predicted Microbiological Human Health Risks Associated with de Facto, Indirect, and Direct Potable Water Reuse.
    Soller JA; Eftim SE; Nappier SP
    Environ Sci Technol; 2019 Nov; 53(22):13382-13389. PubMed ID: 31577425
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advanced oxidation of recalcitrant chromophores in full-scale MBR effluent for non-potable reuse of leachate co-treated municipal wastewater.
    Yin R; Heuzard A; Li T; Ruan X; Lu S; Shang C
    Chemosphere; 2024 Mar; 351():141228. PubMed ID: 38237782
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reliability of pathogen control in direct potable reuse: Performance evaluation and QMRA of a full-scale 1 MGD advanced treatment train.
    Pecson BM; Triolo SC; Olivieri S; Chen EC; Pisarenko AN; Yang CC; Olivieri A; Haas CN; Trussell RS; Trussell RR
    Water Res; 2017 Oct; 122():258-268. PubMed ID: 28609729
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Health risk assessment of organic micropollutants in greywater for potable reuse.
    Etchepare R; van der Hoek JP
    Water Res; 2015 Apr; 72():186-98. PubMed ID: 25472689
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Greywater reuse - Assessment of the health risk induced by Legionella pneumophila.
    Blanky M; Sharaby Y; Rodríguez-Martínez S; Halpern M; Friedler E
    Water Res; 2017 Nov; 125():410-417. PubMed ID: 28889040
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.